BMNR
Bitmine Immersion Technologies, Inc.
There isn't enough reported data to score BMNR yet.
MS
Morgan Stanley
MS's fundamentals are strong: revenue grew 16% and earnings per share grew 29%. At 15x earnings, it's trading in line with its usual 14x. Analysts expect earnings growth.
BMNR Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| N/A | |
| N/A |
BMNR's revenue is currently strong, but its profitability is weak. Free cash flow and net leverage aren't meaningful measures for financial services companies like BMNR.
MS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
MS's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like MS.
BMNR PE Valuation
BMNR has no meaningful PE right now: it lost money over the past year.
MS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 11x | $134 | -29% |
| Fair | 14x | $178 | -5.7% |
| Forward | 14x | $189 | — |
| Current | 15x | $189 | — |
| Expensive | 18x | $223 | +18% |
Historical ranges are pointers, not guarantees.
MS's PE is in its fair range at 15x. If earnings grow as analysts expect, today's price would be 14x next year's earnings.
BMNR Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Strong growth | |
| -- | |
| Limited | |
| High |
Analysts expect strong earnings and revenue growth for BMNR, with profitability holding steady.
MS Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for MS, with profitability improving.
BMNR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.14 | — |
| Q3 2024 | -$1.40 | -$0.40 |
| Q2 2024 | -$1.40 | -$0.45 |
| Q1 2024 | -$1.40 | -$0.45 |
| Q4 2023 | -$1.20 | -$0.40 |
| Q3 2023 | -$1.00 | $0.00 |
MS has the stronger earnings trend. Trailing diluted EPS is down 1,036% for BMNR versus MS up 29%.
MS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.39 | +6.3% |
| Q3 2026 | $12.60 | +29% |
| Q2 2026 | $12.37 | +40% |
| Q1 2026 | $11.04 | +29% |
| Q4 2025 | $10.21 | +28% |
| Q3 2025 | $9.76 | +48% |
| Q2 2025 | $8.84 | +45% |
| Q1 2025 | $8.53 | +55% |
| Q4 2024 | $7.95 | +53% |
MS's earnings per share have climbed steadily: $12.60 over the past year, up 29% from the year before, and higher year over year for 10 quarters in a row.
BMNR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $64.9M | +4802% |
| Q2 2026 | $46.5M | +2168% |
| Q1 2026 | $11M | +628% |
| Q4 2025 | $2.3M | +91% |
| Q3 2025 | $1.3M | +94% |
| Q2 2025 | $2.1M | +67% |
| Q1 2025 | $1.5M | +70% |
| Q4 2024 | $1.2M | +135% |
BMNR has the edge over MS on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 4347% | -29352 points |
| Q2 2026 | -26% | -2.7 points |
| Q1 2026 | -34785% | -34725 points |
| Q4 2025 | -238565% | -238491 points |
| Q3 2025 | 33699% | +33796 points |
| Q2 2025 | -23% | +21 points |
| Q1 2025 | -60% | +13 points |
| Q4 2024 | -74% | +46 points |
BMNR has the edge over MS on profitability, with a higher operating margin.
MS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.3B | +12% |
| Q2 2026 | $21.3B | +27% |
| Q1 2026 | $20.6B | +16% |
| Q4 2025 | $17.9B | +10% |
| Q3 2025 | $18.2B | +18% |
| Q2 2025 | $16.8B | +12% |
| Q1 2025 | $17.7B | +17% |
| Q4 2024 | $16.2B | +26% |
MS's revenue has grown year over year for 14 quarters in a row: $20.3B last quarter, up 12% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 32% | -1.2 points |
| Q2 2026 | 34% | +6.9 points |
| Q1 2026 | 34% | +2.8 points |
| Q4 2025 | 32% | +2 points |
| Q3 2025 | 33% | +5.6 points |
| Q2 2025 | 28% | +0.4 points |
| Q1 2025 | 31% | +2.2 points |
| Q4 2024 | 30% | +14 points |
MS's operating margin was 32% last quarter, down 1.2 points from the same quarter a year ago.
BMNR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$17.6M | -$11M |
| Q2 2026 | $29M | +1629% |
| Q1 2026 | -$88.2M | -$88M |
| Q4 2025 | -$228.7M | -$228.6M |
| Q3 2025 | -$6.6M | -3106% |
| Q2 2025 | $1.7M | +$1.7M |
| Q1 2025 | -$214.2K | -$77.6K |
| Q4 2024 | -$113.9K | +$11.1K |
BMNR's free cash flow was −$306M over the past year, against −$5M the year before. Free cash flow isn't a meaningful measure for financial services companies like BMNR.
MS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$46B | -$42.7B |
| Q2 2026 | -$2.7B | -123% |
| Q1 2026 | -$7.1B | +$16.9B |
| Q4 2025 | -$2.4B | -120% |
| Q3 2025 | -$3.3B | +$14B |
| Q2 2025 | $11.8B | +368% |
| Q1 2025 | -$24B | -650% |
| Q4 2024 | $11.8B | +$29.6B |
MS has the edge over BMNR on cash flow, with more consistent year-over-year improvement.
BMNR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +21% | +97.2M shares |
| 1 year | +27721% | +550M shares |
| 3 years | +25500% | +550M shares |
BMNR has 552M diluted shares, up 27721% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | — |
MS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.2% | -3M shares |
| 1 year | -1.5% | -24M shares |
| 3 years | -4.7% | -77M shares |
| 5 years | -14% | -246M shares |
| Available history | -4.5% | -74M shares |
MS has the edge over BMNR on shareholder dilution, with a more favorable share count trend.
BMNR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2025 | -1.2x | Net Cash |
| Q3 2014 | 37.0x | High |
| Q1 2014 | 557.6x | High |
BMNR has more cash than debt. Net leverage isn't a meaningful measure for financial services companies like BMNR.
MS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 7.8x | High |
| Q2 2026 | 7.3x | High |
| Q1 2026 | 8.2x | High |
| Q4 2025 | 8.6x | High |
| Q3 2025 | 8.4x | High |
| Q2 2025 | 8.7x | High |
| Q1 2025 | 8.7x | High |
| Q4 2024 | 7.9x | High |
MS's net debt is about 7.8 years of its operating earnings (EBITDA), down from 8.4 years a year ago. Net leverage isn't a meaningful measure for financial services companies like MS.
BMNR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 41.3 | Neutral |
| Stochastic | 19.2 | Oversold |
BMNR's weekly RSI is 41 (neutral) and its Stochastic is 19 (oversold).
MS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 45.0 | Neutral |
| Stochastic | 18.7 | Oversold |
MS's weekly RSI is 45 (neutral) and its Stochastic is 19 (oversold).
BMNR PE vs Financial Services Sector
BMNR has no meaningful PE right now: it lost money over the past year.
MS PE vs Financial Services Sector
| Metric | MS | Sector median | Relative |
|---|---|---|---|
| PE | 15x | 13x | 15% above |
| PE % | 59 | 63 | 4 pts below |
MS is trading at 15x earnings, a 15% premium to the Financial Services sector's median of 13x.
BMNR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $22.4 | 18% below |
| 20 week MA | $20.9 | 12% below |
| 50 week MA | $22.0 | 16% below |
MS has stronger trend alignment. BMNR is above 0 of 3 weekly averages versus MS above 3 of 5.
MS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $186.5 | 1.5% above |
| 20 week MA | $203.3 | 6.9% below |
| 50 week MA | $191.9 | 1.4% below |
| 100 week MA | $164.9 | 15% above |
| 200 week MA | $129.3 | 46% above |
MS's trend is mixed: it's above three of its five weekly moving averages, and 46% above its 200-week average.
BMNR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2025 | $15.0 | $28.3 | +89% |
| 2026 YTD | $28.3 | $18.5 | -35% |
BMNR has finished every year since 2025 higher, and it's down 35% so far in 2026.
MS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $51.1 | $68.1 | +33% |
| 2021 | $68.1 | $99.3 | +46% |
| 2022 | $99.3 | $86.1 | -13% |
| 2023 | $86.1 | $93.3 | +8.3% |
| 2024 | $93.3 | $126.8 | +36% |
| 2025 | $126.8 | $181.9 | +43% |
| 2026 YTD | $181.9 | $189.2 | +4% |
MS has the edge over BMNR on returns for 2026, with the stronger performance.